Cargando…

Recent developments in PD-1/PD-L1 blockade research for gastroesophageal malignancies

Gastroesophageal cancers (GECs) comprise malignancies in the stomach, esophagus, and gastroesophageal junction. Despite ongoing improvements in chemoradiotherapy, the clinical outcomes of GEC have not significantly improved over the years, and treatment remains challenging. Immune checkpoint inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Meng, Li, Chenyan, Sun, Mingjun, Li, Yiling, Sun, Xuren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731511/
https://www.ncbi.nlm.nih.gov/pubmed/36505480
http://dx.doi.org/10.3389/fimmu.2022.1043517